Noelle joined the drug discovery group as a Research Associate under Dr. Greg Carr in July, 2016. Noelle has a B.S. in neuroscience from St. Lawrence University and after graduating worked in the Center for Musculoskeletal Research at the University of Rochester as a lab technician. In previous work Noelle studied several areas of research including rodent models of drug addiction, the use of nanoparticles to treat neurodegenerative diseases, and bone marrow mesenchymal stem cells during aging to pursue potential treatments for osteoporosis. At Lieber Noelle works as part of the in vivo drug discovery team to continue to follow her research interests in the development of novel treatments for schizophrenia and other psychiatric disorders.
LIBD Speaker Series: Eli A. Stahl, Ph.D.
Parsing the hits in neuropsych disorders: pathways, networks and transcriptomes. Eli A. Stahl, Ph.D. Assistant Professor Genetics and Genomic Sciences, Psychiatry Icahn School of Medicine at Mount Sinai When: November 28 3:00pm-4:00pm Where: The Lieber Institute for Brain Development Rangos […]